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Smoking is a difficult addiction to break with many
smokers persisting in tobacco use for numerous years, and
typically cycling through multiple periods of remission and
relapse [1]. Yet, while smoking cessation may be the most
desirable final outcome, substitution of conventional
cigarettes by alternative non-combusted forms of nicotine
delivery, such as electronic cigarettes (ECs), is now a
realistic compromise that is likely to eliminate or sub-
stantially reduce exposure to tobacco smoke toxicants [2].
ECs were first marketed 10 years ago, and are now
widely used as long-term substitutes for tobacco cigarettes
primarily because they share sufficient similarities with
bio-behavioural and sensorial aspects of smoking [3].
Designed to enable inhalation of flavoured liquids, in
which pharmaceutical grade nicotine may (or may not) be
added, these battery-operated vaporizers do not contain
tobacco. Nonetheless, ECs are now legally considered to be
tobacco products in the European Union and in the United
States.
The scientific evidence indicates that ECs are much less
harmful than conventional cigarettes [4, 5]. Despite their
reduced risk profile, questions remain as to whether ECs
are effective aids for smoking cessation, promote uptake by
nontobacco users, sustain nicotine dependency via dual
use, slow intentions to quit in dual users, or encourage
relapse to cigarette use among former smokers [6].
Unfortunately, existing observational and epidemiological
studies are largely uninformative due to severe methodolog-
ical limitations. Much of the early population-level studies on
adult EC use have relied on crude measures of use: (such as
‘‘once or more in the past 30 days’’, or ‘‘ever use’’) which do
not capture frequency, intensity, or reasons for use [7–9]; such
defective definitions of current EC use will include many
infrequent users (mostly experimenters unlikely to use ECs
regularly), thus abnormally inflating these statistics and pro-
viding misleading conclusions about the individual as well as
public health impact of ECs. Notably, experimentation with
ECs is now associated with an accelerated rate of decline in
smoking among youths [10–12].
More realistic insights of greater public health relevance
can be drawn by studies that assess, with greater precision,
why, how and what smokers are using as tobacco substi-
tutes. For example, frequency of use (daily vs non-daily)
and type of EC device (advanced open tank systems vs
basic cigalikes) are associated with cigarette abstinence—
daily users of more efficient EC kits are most successful
[13, 14]. Specifying the reason for using ECs (to quit
smoking vs out of curiosity), as well as the presence of
nicotine (vs its absence), are also important determinants of
success [15, 16].
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Some of these critical measurement issues have been
addressed in a recent cross-sectional study of a represen-
tative sample of 27,801 respondents from 28 EU member
states [17]. In particular, the study herein examines current
daily EC use, including current daily nicotine use.
There are several important findings. Among never
smokers, only minimal current daily (0.08%) and current
daily nicotine-containing EC use (0.04%) is observed. By
comparison, daily vaping is reported by 2.31% of current
smokers and 2.18% of former smokers, the vast majority of
whom reported vaping nicotine. As one would expect,
daily EC use is highly prevalent among current and former
smokers, but rare in never smokers. Compared to never
smokers, current and former smokers are at least 50 times
more likely to report daily EC use, which would suggest
that vapor products are extremely unlikely to create daily
nicotine dependence (just 4 in 10,000 never smokers).
Thus, it does not appear that the threat of ECs attracting a
new generation of nicotine addicts has materialized.
Considering that ECs are much less harmful alternatives
to tobacco cigarettes, and that smoking prevalence in the
2014 Eurobarometer survey is still high at 26.4%, regular
EC use of about 2% for the overall sample is disappoint-
ingly low, and it is unlikely to have the significant public
health impact it could have if a harm reduction strategy
was adopted by the public health community. Several
factors might have contributed to such low uptake. For
example, irresponsible science, careless publishing, and
credulous journalism have increasingly fuelled alarmist
and deeply misleading stories about potential harm of these
products. These stories are now spreading fear and confu-
sion, and have actually resulted in public perceptions
shifting in the wrong direction so that ECs are now mis-
perceived as equal to or more harmful than cigarettes,
possibly resulting in some users going back to cigarettes, or
not being open to even trying them. Moreover, the distor-
tion of the scientific evidence of harms has also been
misused and exaggerated thus undermining switching and
slowing of speeding up the end game of eliminating
smoked tobacco rather than eliminating any and all nico-
tine product use for adults. Promoting further access to ECs
and making these products widely available may offer an
opportunity to reduce or prevent some of the otherwise
inevitable burden of premature death and disability caused
by tobacco smoking [18].
Interactions between changes in smoking behaviour and
daily EC use were also investigated. Although the cross-
sectional design of the 2014 Eurobarometer survey cannot
establish cause and effect, another important finding is that
nearly half of all daily EC users have quit smoking com-
pletely (by vaping). Clearly, improved characterization of
frequency of use as well as nicotine provision appears to
play a major role when evaluating smoking cessation. A
possible explanation is that regular daily EC use might
have assisted many EC users to build up the necessary
confidence to do something good for their health, and to
stay quit or reduce cigarette consumption. The same logic
may also explain the low level of relapse observed in the
sample.
EC use is a complex and dynamically evolving beha-
viour. Its definition and detailed characterization of con-
current EC and cigarette use requires thoughtful and
careful assessment. Therefore, to advance knowledge of
the impact of EC use on smoking status, it will be neces-
sary to conduct prospective studies considering relevant
descriptors of vaping behaviour such as frequency of use
(e.g. focusing on daily users, and not just to those who are
experimenting), reasons for using ECs (e.g. to quit smoking
vs out of curiosity), and product design (e.g. closed vs open
systems; nicotine containing vs non-nicotine containing
products; etc.). Reasons for vaping, the type of device and
e-liquid, frequency of use, and the accompanying sensory
and craving-control experiences will have some impact on
smoking behaviors (cutting down, quitting). Only carefully
conducted longitudinal studies will be able to indicate
which combinations of device and human use factors are
likely to lead to sustained, beneficial outcomes.
In any case the study by Farsalinos and colleagues [17]
is important because by addressing some of the common
methodological mistakes present in the vast majority of
existing observational and epidemiological studies, it pro-
vides a more realistic estimate of current regular EC use,
and of its impact on smoking habits. Despite some mixed
and negative results from many early epidemiological
studies with serious methodological limitations, a common
theme that seems to be emerging is that if a smoker persists
in seeking out and finding an EC that is satisfying to him/
her (including flavors) and persists in regular use, he/she is
more likely to switch or quit. By exploring diversities and
similarities among different product designs, smokers are
now beginning to learn that adoption rates (and conse-
quently the extent of reduction in tobacco consumption),
are intimately associated with their efficiency as smoking
‘‘sensation’’ products, with smoking cessation becoming a
‘‘collateral benefit’’ for many smokers switching to regular
daily EC use [19–21].
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